Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of 125.92 million as of April 24, 2025. Its market cap has decreased by -19.24% in one year.

Market Cap

125.92M

Enterprise Value

83.43M

Revenue

16.64M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.74

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 530.53K to 125.92M, an increase of 23,634.83%. That is a compound annual growth rate of 34.43%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	129.40M	-2.17%
Dec 31, 2024	132.26M	-27.85%
Dec 29, 2023	183.31M	-21.67%
Dec 30, 2022	234.02M	-20.77%
Dec 31, 2021	295.36M	20.59%
Dec 31, 2020	244.93M	-38.25%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	157.23B
Shell	146.99B
HSBC Holdings	140.74B
Unilever	120.20B
Rio Tinto Group	75.78B
RELX PLC	72.45B
British American Tobacco p.l.c.	70.11B
London Stock Exchange Group	61.21B

Market Cap Rankings